DOI: http://dx.doi.org/10.18203/2320-6012.ijrms20205333

Talaromycosis in Assam: a case report

Nilakshi Borah, Ajanta Sharma, Lahari Saikia

Abstract


Talaromycosis is an opportunistic infection caused by a dimorphic fungus, Talaromyces marneffei. We describe here a case of 38 years old HIV seropositive male patient from Assam presented with fever, cough, weight loss and discrete, multiple, umbilicated papules and nodules in face and upper trunk. Differential diagnosis of histoplasmosis, giant molluscum contagiosum and talaromycosis were considered. Histopathological and mycological study of skin biopsy tissue confirmed the diagnosis of talaromycosis. Primary treatment with amphotericin B and itraconazole showed promising results. Early diagnosis and adequate antifungal therapy are imperative to avoid the complications. Talaromyces requires further in-depth study with respect to its global distribution, natural history, pathogenesis and the impact of antiretroviral therapy.


Keywords


Talaromycosis, Talaromyces marneffei, Dimorphic fungus, HIV, Amphotericin B

Full Text:

PDF

References


Bradsher RW. Geographic, travel and occupational fungal infections. In: Anaissie EJ, McGinnis MR, P faller MA,editors. Clinical Mycology. 1sted. New York: Churchill Livingstone. 2003:583-7.

Viviani MA, Tortorano AM. Penicillium marneffei. In:Collier L, Balows A, Sussman M, editors. Topley& Wilson’s Microbiology and Microbial Infections. 9th e. London: Arnold;1998:409-18.

Chander J. Talaromycosis. In:Textbook of Medical Mycology, 4th edition. New Delhi: Jaypee Publishers; 2018:506-23.

Sirisanthana T, Supparatpinyo K. Epidemiology and management of penicilliosis in human immunodeficiency virus-infected patients. Int J Infect Dis. 1998;3(1):48-53

DiSalvo AF, Fickling AM, Ajello L. Infection caused by Penicillium marneffei: description of first natural infection in man. Am J Clin Pathol. 1973;59:259-63

Piehl MR, Kaplan RL, Haber MH. Disseminated penicillioisis in a patient with acquired immunodeficiency syndrome. Arch Pathol Lab Med. 1988;112:1262-4

Nittayananta W. Penicilliosis marneffei: Another AIDS defining illness in Southeast Asia. Oral Dis. 1999;286-93

Ranjana KH, Priyokumar K, Singh TJ, Gupta CC, Sharmila L, Singh PN, et al. Disseminated Penicillium marneffei infection among HIV –infected patients in Manipur State, India. J Infect. 2002;45:268-71

Varghese GM, Pise G, Michael SJ, Jacob M, George R. Disseminated Penicillium marneffei infection in a human immunodeficiency virus-infected individual. J Postgrad Med. 2004;50:235-6

Cooper CR, McGinnis MR. Pathology of Penicillium marneffei.An emerging acquired immunodeficiency syndrome related pathogen.ArchPathol Lab Med. 1997;121:798-804

Srisanthana T. Infection due to Penicillium marneffei. In: Warrell DA, Cox TM, Firth JD, editors. Oxford Textbook of Medicine. 4thed. New York: Oxford University Press;2003:712-3.

Devi SB, Devi TS, Ningshen R, Devi Kh R, Singh TB, Singh NB. Penicillium marneffei, an emerging AIDS related pathogen- a RIMS study. J Ind Med Assoc. 2009;107(4):208-10

Supparatpinyo K, Khamwan C, Baosoung V, Nelson KE, Sirisanthana T. Disseminated Penicillium marneffei infection in Southeast Asia. Lance. 1994;344:110-3

Deesomchok A, Tanprawate S. A 12 case series of Penicillium marneffei pneumonia. J Medic Assoc Thai. 2006;89(4):441-7

Wu TC, Chan JWM, Ng CK, Tsang DNC, Lee M P, Li PCK. Clinical presentations and outcomes of Penicillium marneffei infections: a series from 1994 to 2004. Ho Ko Medic J. 2008;14(2):103-9

Kantipong P, Panich V, Pongsurachet V, Watt G. Hepatic penicilliosis in patients without skin lesions. Clin Infect Dis. 1998;26(5):1215-7

Chariyalertsak S, Sirisanthana T, Supparatpinyo K, Praparattanapan J, Nelson K. Case-control study of risk factors for Penicillium marneffei infection in human immunodeficiency virus infected patients in northern Thailand. Clin Infect Dis. 1997;24:1080-6

Chariyalertsak S, Vanittanakom P, Nelson K, Sirisanthana T, Vanittanakom N. Rhizomys sumatrensis and Cannomys badius, new natural animal hosts of Penicillium marneffei. J Med Vet Mycol. 1996;34:105-10

Deng Z, Ribas J, Gibson D, Connor D. Infections caused by Penicillium marneffei in China and Southeast Asia: review of eighteen published cases and report of four more Chinese cases. Rev Infect Dis. 1988;10:640-52.

Chastain DB, Henao-Martinez AF, Franco-Paredes C. Opportunistic invasive mycoses in AIDS: crypyococcosis, histoplasmosis, coccidiodomycosis, and talaromycosis. Curr Infect Dis Rep. 2017;19:36.

Boon-Long J, Mekha N, Poonwan N. In vitro antifungal activity of the new triazole DO870 against Penicillium marneffei compared with that of amphotericin B, fluconazole, itraconazole, miconazole and flucytosine. Mycoses. 1996;39(11-12):453-56

Sekhon AS, Garg AK, Padhye AA, Hamir Z. In vitro susceptibility of mycelial and yeast forms of Penicillium marneffei to amphotericin B, fluconazole, 5-fluorocytosine and itraconazole. Europ J Epidemiol. 1993;9(5):553-8.

Nakai T, Uno J, Ikeda F, Tawara S, Nishimura K, Miyaji M. In vitro antifungal activity of micafungin (FK463) against dimorphic fungi: comparison of yeast-like and mycelial forms. Antimicrob Agen Chemother. 2003;47(4):1376-81

Radford SA, Johnson EM, Warnock DW. In vitro studies of activity of Voriconazole, a new triazole antifungal agent, against emerging and less-common mold pathogens. Antimicrob Agents Chemther 1997;41:841-3

Supparatpinyo K, Nelson KE, Merz WG, Breslin BJ, Cooper CR, Kamwan C, et al. Response to antifungal therapy by human immunodeficiency virus infected patients with disseminated Penicillium marneffei infections and in vitro susceptibilities of isolates from clinical specimens. Antimicrod Agents Chemother. 1993;37(11):2407-11

Devi B, Sana S, Meka B, Raj B. Disseminated talaromycosis: an AIDS defining fungal infection. Int J Res Dermatol. 2020;6:676-9

Gorai S, Saha M, Madhab V, Mitra S. Talaromycosis (Penicilliosis): A rare, opportunistic systemic fungal infection. Ind J Dermatol. 2019;64:331-3

Sarkar S, Saha A, Shukla S. Two sporadic cases of Penicillium marneffei infection associated with human immunodeficiency virus infection from West Bengal: A word of caution. Indian J Sex Transm Dis AIDS. 2019;40(2):180-2

Wongkamhla T, Chongtrakool P, Jitmuang A. A case report of Talaromyces marneffei Oro-pharyngo-laryngitis: a rare manifestation of Talaromycosis. Bio Med Centr Infect Disea. 2019;19:1034

Lalnunhlua HC, Devi SB, Chanu KJ, Singh KB. Hoarseness due to Penicillium marneffei infection-an unusual presentation. Int J Med and Dent Sci. 2017;6(1):1426-9.

Saikia L, Nath R, Mahanta J. Penicillium marneffei infection in Assam. Indian J Dermatol Venerol Leprol. 2010;76:75-6.

Sood N, Gugnani HC. Disseminated Penicillium marneffei infection in a Myanmar refugee from Mizoram state. Indian J of Pathol and Microbiol. 2010;53(2):361-3.

George IA, Sudarsan TD, Pulimood AB, Mathews MS. Acute abdomen: an unusual presentation of disseminated Penicillium marneffei infection. Ind J Medic Microbiol. 2008;26(2);180-95.

Sharma A, Hazarika NK, Barua P. Penicillium marneffei infection in a HIV infected child. Ind J Med Res. 2007;126:580-2.

Chaiwun B, Khunamornpong S, Sirivanichai C, Rangdaeng S, Supparatpinyo K, Settakorn J et al. Lymphadenopathy due to Penicillium marneffei infection: Diagnosis by Fine needle aspiration cytology. Mod Pathol. 2002;15(9):939-43.

Singh PN, Ranjana K, Singh I, Singh KP, Sharma SS et al. Indigenous Disseminated Penicillium marneffei Infection in the State of Manipur, India: Report of Four Autochthonous cases. J Clin Microbiol. 1999;37(8):2699-702.